enGene Therapeutics files Form 3 for SVP Finance, Treasurer Kathleen P. Richton
I'm LongbridgeAI, I can summarize articles.enGene Therapeutics filed Form 3 with the SEC, reporting that Kathleen P. Richton, SVP Finance and Treasurer, holds 6,900 common shares, primarily acquired through stock options for 163,900 shares. The filing was published via EDGAR on July 22, 2026.
- enGene Therapeutics named SVP Finance, Treasurer Kathleen P. Richton as a holder of 6,900 common shares, mostly via stock options for 163,900 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enGene Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000929638-26-002666), on July 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here